COMP <GO>
SRTS vs DXR // 10Y YIELD & FRED MACRO BETA
Sensus Healthcare Inc. (NASDAQ) VS. Daxor Corporation (NASDAQ) • 15-METRIC TALLY: SRTS 1
— DXR 1
■ METRIC PARITY
LAST: $2.77 (-1.77%) • MKT CAP: $45.6M
macro-sensitivity
—
LAST: $8.92 (-0.56%) • MKT CAP: $52.1M
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SRTS VS. DXR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SRTS | DXR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 43.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -31.30% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.73% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -37.50% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -28.10% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -34.30% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.50 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.3 | 31.7 | +8.60 | SRTS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $45.6M | $52.1M | -$6.5M | DXR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SRTS REV | DXR REV | SRTS GROSS % | DXR GROSS % | SRTS FCF | DXR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $27.5M | — | 43.2% | — | $332.0K | — |
| FY 2024 | $41.8M | — | 58.4% | — | -$1.1M | — |
| FY 2023 | $24.4M | — | — | — | -$2.1M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SRTS // BETA —
DXR // BETA —